Agenus (AGEN) Non Operating Income (2010 - 2026)
Agenus' (AGEN) quarterly Non Operating Income came in at -$208000.0 in Q1 2026, up 21.21% year-on-year from -$171600.0 in Q1 2025, and up 99.42% quarter-over-quarter from -$35.7 million in Q4 2025.
Agenus (AGEN) Non Operating Income (2010 - 2026) Analysis & Trends
Agenus' Non Operating Income history runs 17 years deep, the most recent figure standing at -$208000.0 for Q1 2026.
- On a quarterly basis, Non Operating Income rose 21.21% year-over-year to -$208000.0 in Q1 2026; TTM through Mar 2026 was -$55.2 million, a 71.15% increase from a year earlier, with the FY2025 full-year figure at -$55.3 million, up 53.01% from the prior year.
- Non Operating Income rose to -$208000.0 in Q1 2026 per AGEN's latest filing, from -$35.7 million in the prior quarter.
- Across five years, Non Operating Income topped out at $9.1 million in Q2 2022 and bottomed at -$123.7 million in Q4 2024.
- The 5-year median for Non Operating Income is -$17.3 million (2022), against an average of -$24.5 million.
- Across the five-year window, Non Operating Income soared 1084.89% in 2022 and tumbled 73765.0% in 2024, its largest moves.
- Year by year, Non Operating Income stood at -$17.3 million in 2022, then tumbled by 466.6% to -$98.2 million in 2023, then slipped by 25.99% to -$123.7 million in 2024, then soared by 71.14% to -$35.7 million in 2025, then surged by 99.42% to -$208000.0 in 2026.
- Per Business Quant, the three latest AGEN Non Operating Income figures stand at -$208000.0 (Q1 2026), -$35.7 million (Q4 2025), and -$19.3 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -9.22 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 188.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 5.75 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -8.59 Mn |
| 10 | Agenus | 184.05 Mn | 177.29 Mn | 33.74 Mn | -208,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -208,000.00 |
| Dec 31, 2025 | -35.70 Mn |
| Sep 30, 2025 | -19.30 Mn |
| Jun 30, 2025 | -12,000.00 |
| Mar 31, 2025 | -264,000.00 |
| Dec 31, 2024 | -123.68 Mn |
| Sep 30, 2024 | -35.73 Mn |
| Jun 30, 2024 | -31.75 Mn |
| Mar 31, 2024 | -29.47 Mn |
| Dec 31, 2023 | -98.16 Mn |
| Sep 30, 2023 | -18.63 Mn |
| Jun 30, 2023 | -244,000.00 |
| Mar 31, 2023 | 40,000.00 |
| Dec 31, 2022 | -17.33 Mn |
| Sep 30, 2022 | 537,000.00 |
| Jun 30, 2022 | 9.06 Mn |
| Mar 31, 2022 | -15.20 Mn |
| Dec 31, 2021 | 54.20 Mn |
| Sep 30, 2021 | 121,000.00 |
| Jun 30, 2021 | -920,000.00 |